De Vivo DC, Bohan TP, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives.
Epilepsia
39: 1216 - 1225, 1998.
Coulter DL. Carnitine deficiency: a possible mechanism for valproate hepatotoxicity [letter].
Lancet
1: 689, 1984.
Ater SB, et al. A developmental center population treated with VPA and L-carnitine. In: Update 1993: inborn errors of metabolism in the patient with epilepsy. Sigma-Tau Pharmaceuticals; 1993.
Dreifuss FE and Langer DH. Hepatic considerations in the use of antiepileptic drugs.
Epilepsia
28(suppl 2): S23 - S29, 1987.
Ater SB, et al. A developmental center population treated with VPA and L-carnitine. In: Update 1993: inborn errors of metabolism in the patient with epilepsy. Sigma-Tau Pharmaceuticals; 1993.
Freeman JM, Vining EP, Cost S, et al. Does carnitine administration improve the symptoms attributed to anticonvulsant medications? A double-blinded, crossover study.
Pediatrics
93: 893 - 895, 1994.
De Vivo DC, Bohan TP, Coulter DL, et al. L-carnitine supplementation in childhood epilepsy: current perspectives.
Epilepsia
39: 1216 - 1225, 1998.
Tomita S, Ohnishi J, Nakano M, and Ichikawa Y. The effects of anticonvulsant drugs on vitamin D
3
-activating cytochrome P-450-linked monooxygenase systems.
J Steroid Biochem Mol Biol
39: 479 - 485, 1991.
Hendel J, Dam M, Gram L, et al. The effects of carbamazepine and valproate on folate metabolism in man.
Acta Neurol Scand
69: 226 - 231, 1984.
Kishi T, Fujita N, Eguchi T, et al. Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy.
J Neurol Sci
145: 109 - 112, 1997.
Reynolds EH. Mental effects of anticonvulsants, and folic acid metabolism.
Brain
91: 197 - 214, 1968.
Berg MJ, Stumbo PJ, Chenard CA, et al. Folic acid improves phenytoin pharmacokinetics.
J Am Diet Assoc
95: 352 - 356, 1995.
Lewis DP, Van Dyke DC, Willhite LA, et al. Phenytoin-folic acid interaction.
Ann Pharmacother
29: 726 - 735, 1995.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother
32: 802 - 817, 1998.
Ono H, Sakamoto A, Eguchi T, et al. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants.
Metabolism
46: 959 - 962, 1997.
Lewis DP, Van Dyke DC, Stumbo PJ, et al. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate.
Ann Pharmacother
32: 802 - 817, 1998.
Krause K-H, Bonjour J-P, Berlit P, et al. Biotin status of epileptics.
Ann N Y Acad Sci
447: 297 - 313, 1985.
Said HM, Redha R, and Nylander W. Biotin transport in the human intestine: inhibition by anticonvulsant drugs.
Am J Clin Nutr
49: 127 - 131, 1989.
Nau H, Tzimas G, Mondry M, et al. Antiepileptic drugs alter endogenous retinoid concentrations: a possible mechanism of teratogenesis of anticonvulsant therapy.
Life Sci
57: 53 - 60, 1995.
Arenz A, Klein M, Fiehe K, et al. Occurrence of neurotoxic 4'-O-methylpyridoxine in
Ginkgo biloba
leaves, ginkgo medications and Japanese ginkgo food.
Planta Med
62: 548 - 551, 1996.
Mizuno N, Kawakami K, and Morita E. Competitive inhibition between 4'-substituted pyridoxine analogues and pyridoxal for pyridoxal kinase from mouse brain.
J Nutr Sci Vitaminol (Tokyo)
26: 535 - 543, 1980.
Wada K, Ishigaki S, Ueda K, et al. An antivitamin B
6, 4'-methoxypyridoxine, from the seed of
Ginkgo biloba
L.
Chem Pharm Bull (Tokyo)
33: 3555 - 3557, 1985.
Yagi M, Wada K, Sakata M, et al. Studies on the constituents of edible and medicinal plants. IV. Determination of 4-O-methylpyridoxine in serum of the patient with gin-nan food poisoning [in Japanese; English abstract].
Yakugaku Zasshi
113: 596 - 599, 1993.
Arenz A, Klein M, Fiehe K, et al. Occurrence of neurotoxic 4'-O-methylpyridoxine in
Ginkgo biloba
leaves, ginkgo medications and Japanese ginkgo food.
Planta Med
62: 548 - 551, 1996.
Último revisado julio 2012 por EBSCO CAM Review Board
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.
Copyright © EBSCO Publishing. All rights reserved.